• Home
  • Stock
  • Glenmark Pharmaceuticals Fundamental Analysis
  • Glenmark Pharmaceuticals Fundamental Analysis

Glenmark Pharmaceuticals fundamental analysis

GLENMARK

HealthcareLarge

1844.2

33.80 (-1.80%)
Last updated on 21 Nov, 2025 | 15:51 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Glenmark Pharmaceuticals Fundamentals

P/E Ratio

51.56

P/B Ratio

5.43

Div. Yield

0.14

Sector P/E

37.28

Sector P/B

3.6

Sec. Div. Yield

0.57

  • Glenmark Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 51.56, compared to the sector average of 37.28. Its P/B Ratio stands at 5.43, while the sector’s is 3.6. In terms of returns, the stock offers a Dividend Yield of 0.14%, which is than the sector’s 0.57%.

Glenmark Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Moderate

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Glenmark Pharmaceuticals reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.